Variants in Mitochondrial ATP Synthase Cause Variable Neurologic Phenotypes.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
02 2022
Historique:
revised: 23 12 2021
received: 23 08 2021
accepted: 24 12 2021
pubmed: 27 12 2021
medline: 11 2 2022
entrez: 26 12 2021
Statut: ppublish

Résumé

ATP synthase (ATPase) is responsible for the majority of ATP production. Nevertheless, disease phenotypes associated with mutations in ATPase subunits are extremely rare. We aimed at expanding the spectrum of ATPase-related diseases. Whole-exome sequencing in cohorts with 2,962 patients diagnosed with mitochondrial disease and/or dystonia and international collaboration were used to identify deleterious variants in ATPase-encoding genes. Findings were complemented by transcriptional and proteomic profiling of patient fibroblasts. ATPase integrity and activity were assayed using cells and tissues from 5 patients. We present 10 total individuals with biallelic or de novo monoallelic variants in nuclear ATPase subunit genes. Three unrelated patients showed the same homozygous missense ATP5F1E mutation (including one published case). An intronic splice-disrupting alteration in compound heterozygosity with a nonsense variant in ATP5PO was found in one patient. Three patients had de novo heterozygous missense variants in ATP5F1A, whereas another 3 were heterozygous for ATP5MC3 de novo missense changes. Bioinformatics methods and populational data supported the variants' pathogenicity. Immunohistochemistry, proteomics, and/or immunoblotting revealed significantly reduced ATPase amounts in association to ATP5F1E and ATP5PO mutations. Diminished activity and/or defective assembly of ATPase was demonstrated by enzymatic assays and/or immunoblotting in patient samples bearing ATP5F1A-p.Arg207His, ATP5MC3-p.Gly79Val, and ATP5MC3-p.Asn106Lys. The associated clinical profiles were heterogeneous, ranging from hypotonia with spontaneous resolution (1/10) to epilepsy with early death (1/10) or variable persistent abnormalities, including movement disorders, developmental delay, intellectual disability, hyperlactatemia, and other neurologic and systemic features. Although potentially reflecting an ascertainment bias, dystonia was common (7/10). Our results establish evidence for a previously unrecognized role of ATPase nuclear-gene defects in phenotypes characterized by neurodevelopmental and neurodegenerative features. ANN NEUROL 2022;91:225-237.

Identifiants

pubmed: 34954817
doi: 10.1002/ana.26293
pmc: PMC9939050
mid: NIHMS1865453
doi:

Substances chimiques

Mitochondrial ADP, ATP Translocases 9068-80-8
ATP5F1A protein, human EC 3.6.1.14
ATP5PD protein, human EC 3.6.3.-
Mitochondrial Proton-Translocating ATPases EC 3.6.3.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

225-237

Subventions

Organisme : Else Kröner-Fresenius-Stiftung
Organisme : NHGRI NIH HHS
ID : R01 HG009141
Pays : United States
Organisme : Federal Ministry of Education and Research
ID : 01GM1906A
Organisme : Technische Universität München
Organisme : NHLBI NIH HHS
ID : R00 HL143036
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG011755
Pays : United States
Organisme : Federal Ministry of Education and Research
ID : I4704-B
Organisme : Federal Ministry of Education and Research
ID : 01KU2016A
Organisme : NINDS NIH HHS
ID : R01 NS106298
Pays : United States
Organisme : Medizinische Universität Innsbruck
Organisme : Ministry of Education
ID : NV19-04-00233
Organisme : NHGRI NIH HHS
ID : UM1 HG008900
Pays : United States
Organisme : Federal Ministry of Education and Research
ID : 01GM1920A
Organisme : Research Foundation
Organisme : Charles University
Organisme : Federal Ministry of Education and Research
ID : I4695-B
Organisme : Helmholtz Zentrum München

Informations de copyright

© 2021 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

J Inherit Metab Dis. 2012 Mar;35(2):211-25
pubmed: 21874297
Life (Basel). 2021 Apr 08;11(4):
pubmed: 33917760
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):2988-2993
pubmed: 29440398
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Hum Mol Genet. 2018 Oct 1;27(19):3305-3312
pubmed: 29917077
Lancet Neurol. 2020 Nov;19(11):908-918
pubmed: 33098801
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Mitochondrion. 2021 Jul;59:169-174
pubmed: 34023438
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Clin Genet. 2019 Oct;96(4):354-358
pubmed: 31290144
Nat Rev Dis Primers. 2016 Oct 20;2:16080
pubmed: 27775730
Brain. 2021 Oct 22;144(9):e74
pubmed: 34165507
Biochim Biophys Acta. 2009 Jan;1793(1):186-99
pubmed: 18620007
Am J Hum Genet. 2018 Mar 1;102(3):494-504
pubmed: 29478781
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Nat Rev Mol Cell Biol. 2001 Sep;2(9):669-77
pubmed: 11533724
Nat Genet. 2020 Oct;52(10):1046-1056
pubmed: 32989326
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8
pubmed: 26582918
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Hum Mol Genet. 2010 Sep 1;19(17):3430-9
pubmed: 20566710
Am J Hum Genet. 2017 Oct 5;101(4):525-538
pubmed: 28942965
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Front Physiol. 2018 Apr 04;9:329
pubmed: 29670542
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169
pubmed: 27899622
Brain. 2013 May;136(Pt 5):1544-54
pubmed: 23599390
Nature. 2020 Oct;586(7831):757-762
pubmed: 33057194
Genome Res. 2001 May;11(5):863-74
pubmed: 11337480
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
EBioMedicine. 2020 Jun;56:102784
pubmed: 32454403
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
J Coll Physicians Surg Pak. 2021 Jul;30(7):811-816
pubmed: 34271781
Mov Disord. 2022 Feb;37(2):375-383
pubmed: 34636445
Front Cell Dev Biol. 2020 Nov 26;8:600079
pubmed: 33324649
Brain Commun. 2021 Apr 07;3(2):fcab063
pubmed: 34056600
FEBS Lett. 2021 Apr;595(8):1132-1158
pubmed: 33655490
Nat Commun. 2017 Jun 12;8:15824
pubmed: 28604674
Neurology. 2013 May 7;80(19):1762-70
pubmed: 23596069

Auteurs

Michael Zech (M)

Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.

Robert Kopajtich (R)

Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.

Katja Steinbrücker (K)

University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.

Céline Bris (C)

Unité Mixte de Recherche MITOVASC, CNRS 6015/INSERM 1083, Université d'Angers, Angers, France.
Département de Biochimie et Génétique, Centre Hospitalier Universitaire d'Angers, Angers, France.

Naig Gueguen (N)

Unité Mixte de Recherche MITOVASC, CNRS 6015/INSERM 1083, Université d'Angers, Angers, France.
Département de Biochimie et Génétique, Centre Hospitalier Universitaire d'Angers, Angers, France.

René G Feichtinger (RG)

University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.

Melanie T Achleitner (MT)

University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.

Neslihan Duzkale (N)

Department of Medical Genetic, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.

Maximilien Périvier (M)

Pediatric Neurology Department, CHU Clocheville, Tours, France.

Johannes Koch (J)

University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.

Harald Engelhardt (H)

Kinderkrankenhaus St. Marien gGmbH, Zentrum für Kinder- und Jugendmedizin, Landshut, Germany.

Peter Freisinger (P)

Children's Hospital Kreiskliniken, Reutlingen, Germany.

Matias Wagner (M)

Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.

Theresa Brunet (T)

Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.

Riccardo Berutti (R)

Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.

Dmitrii Smirnov (D)

Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.

Tharsini Navaratnarajah (T)

Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.

Richard J T Rodenburg (RJT)

Radboud Centre for Mitochondrial Medicine, Department of Paediatrics Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen Medical Centre Nijmegen, Nijmegen, The Netherlands.

Lynn S Pais (LS)

Program in Medical and Population Genetics, Broad Institute, Cambridge, MA.

Christina Austin-Tse (C)

Harvard Medical School & Center for Genomic Medicine, Massachusetts General Hospital, Boston & Laboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Cambridge, MA.

Melanie O'Leary (M)

Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard, Cambridge, MA.

Sylvia Boesch (S)

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Robert Jech (R)

Department of Neurology, Charles University, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.

Somayeh Bakhtiari (S)

Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ.
Departments of Child Health, Neurology, and Cellular & Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine-Phoenix, Phoenix, AZ.

Sheng Chih Jin (SC)

Department of Genetics, Washington University School of Medicine, St. Louis, MO.
Department of Pediatrics, Washington University School of Medicine, St Louis, MO.

Friederike Wilbert (F)

Department of Neuropediatrics and Muscle Disorders, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Michael C Kruer (MC)

Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ.
Departments of Child Health, Neurology, and Cellular & Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine-Phoenix, Phoenix, AZ.

Saskia B Wortmann (SB)

University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.
Radboud Center for Mitochondrial Medicine, Department of Pediatrics, Amalia Children's Hospital, Radboud UMC, Nijmegen, The Netherlands.

Matthias Eckenweiler (M)

Department of Neuropediatrics and Muscle Disorders, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Johannes A Mayr (JA)

University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.

Felix Distelmaier (F)

Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.

Robert Steinfeld (R)

Department of Pediatric Neurology, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.

Juliane Winkelmann (J)

Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
Lehrstuhl für Neurogenetik, Technische Universität München, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Holger Prokisch (H)

Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH